| Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer S Modi, W Jacot, T Yamashita, J Sohn, M Vidal, E Tokunaga, J Tsurutani, ... New England Journal of Medicine 387 (1), 9-20, 2022 | 1128 | 2022 |
| Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting F Amant, P Berveiller, IA Boere, E Cardonick, R Fruscio, M Fumagalli, ... Annals of Oncology 30 (10), 1601-1612, 2019 | 227 | 2019 |
| Trastuzumab administration during pregnancy: a systematic review and meta-analysis F Zagouri, TN Sergentanis, D Chrysikos, CA Papadimitriou, ... Breast cancer research and treatment 137, 349-357, 2013 | 194 | 2013 |
| Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement HA Azim Jr, S Michiels, F Zagouri, S Delaloge, M Filipits, M Namer, ... Annals of oncology 24 (3), 647-654, 2013 | 163 | 2013 |
| Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors MA Dimopoulos, M Roussou, M Gavriatopoulou, F Zagouri, M Migkou, ... Clinical Lymphoma and Myeloma 9 (4), 302-306, 2009 | 155 | 2009 |
| Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis F Zagouri, TN Sergentanis, R Bartsch, AS Berghoff, D Chrysikos, ... Breast cancer research and treatment 139, 13-22, 2013 | 134 | 2013 |
| Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease X Provatopoulou, A Gounaris, E Kalogera, F Zagouri, I Flessas, ... BMC cancer 9, 1-7, 2009 | 133 | 2009 |
| Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis F Zagouri, TN Sergentanis, D Chrysikos, R Bartsch Obstetrics & Gynecology 121 (2 PART 1), 337-343, 2013 | 125 | 2013 |
| Cancer in pregnancy: disentangling treatment modalities F Zagouri, C Dimitrakakis, S Marinopoulos, A Tsigginou, MA Dimopoulos ESMO open 1 (3), e000016, 2016 | 123 | 2016 |
| Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma V Koutoulidis, S Fontara, E Terpos, F Zagouri, D Matsaridis, D Christoulas, ... Radiology 282 (2), 484-493, 2017 | 112 | 2017 |
| Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development GE Theodoropoulos, V Saridakis, T Karantanos, NV Michalopoulos, ... The Breast 21 (4), 534-538, 2012 | 106 | 2012 |
| Risk factors for multiple myeloma: a systematic review of meta-analyses TN Sergentanis, F Zagouri, G Tsilimidos, A Tsagianni, M Tseliou, ... Clinical Lymphoma Myeloma and Leukemia 15 (10), 563-577. e3, 2015 | 101 | 2015 |
| Molecularly targeted therapies in cervical cancer. A systematic review F Zagouri, TN Sergentanis, D Chrysikos, M Filipits, R Bartsch Gynecologic oncology 126 (2), 291-303, 2012 | 96 | 2012 |
| Current clinical practice guidelines for the treatment of renal cell carcinoma: a systematic review and critical evaluation A Bamias, B Escudier, CN Sternberg, F Zagouri, A Dellis, B Djavan, ... The oncologist 22 (6), 667-679, 2017 | 93 | 2017 |
| Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre … F André, YH Park, SB Kim, T Takano, SA Im, G Borges, JP Lima, S Aksoy, ... The Lancet 401 (10390), 1773-1785, 2023 | 92 | 2023 |
| Taxanes for breast cancer during pregnancy: a systematic review F Zagouri, TN Sergentanis, D Chrysikos, C Dimitrakakis, A Tsigginou, ... Clinical Breast Cancer 13 (1), 16-23, 2013 | 91 | 2013 |
| Hsp90 inhibitors in breast cancer: a systematic review F Zagouri, TN Sergentanis, D Chrysikos, CA Papadimitriou, ... The Breast 22 (5), 569-578, 2013 | 88 | 2013 |
| High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer F Zagouri, Z Bago-Horvath, F Rössler, A Brandstetter, R Bartsch, ... British journal of cancer 108 (5), 1100-1105, 2013 | 87 | 2013 |
| Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma F Zagouri, TN Sergentanis, GC Zografos World Journal of Surgical Oncology 5, 1-11, 2007 | 84 | 2007 |
| Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma E Kastritis, F Zagouri, A Symeonidis, M Roussou, A Sioni, A Pouli, ... Leukemia 28 (10), 2075-2079, 2014 | 80 | 2014 |
